EBIT at other companies
Other financials
Where this comes from
Calculated from Relay Therapeutics, Inc.’s reported figures.
The official record: Relay Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relay Therapeutics, Inc.'s ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relay Therapeutics, Inc.'s EBIT?
- Relay Therapeutics, Inc. (RLAY) reported EBIT of -$78.59M in Q1 2026.
- How has Relay Therapeutics, Inc.'s EBIT changed year-over-year?
- Relay Therapeutics, Inc.'s EBIT increased by 7.4% year-over-year, from -$84.87M to -$78.59M.
- What is the long-term trend for Relay Therapeutics, Inc.'s EBIT?
- Over 4 years (2021 to 2025), Relay Therapeutics, Inc.'s EBIT has grown at a -4.5% compound annual growth rate (CAGR), from -$364.7M to -$302.74M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.